{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:34:01Z","timestamp":1795113241984,"version":"4.10.3"},"reference-count":47,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","award":["DK62410-S1"],"award-info":[{"award-number":["DK62410-S1"]}],"id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","award":["DK090728"],"award-info":[{"award-number":["DK090728"]}],"id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences Clinical and Translational Science","doi-asserted-by":"publisher","award":["RR025008"],"award-info":[{"award-number":["RR025008"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences Clinical and Translational Science","doi-asserted-by":"publisher","award":["TR000454"],"award-info":[{"award-number":["TR000454"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences Clinical and Translational Science","doi-asserted-by":"publisher","award":["RR024150"],"award-info":[{"award-number":["RR024150"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences Clinical and Translational Science","doi-asserted-by":"publisher","award":["TR00135"],"award-info":[{"award-number":["TR00135"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences Clinical and Translational Science","doi-asserted-by":"publisher","award":["RR025752"],"award-info":[{"award-number":["RR025752"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences Clinical and Translational Science","doi-asserted-by":"publisher","award":["TR001064"],"award-info":[{"award-number":["TR001064"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences Clinical and Translational Science","doi-asserted-by":"publisher","award":["RR025780"],"award-info":[{"award-number":["RR025780"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences Clinical and Translational Science","doi-asserted-by":"publisher","award":["TR001082"],"award-info":[{"award-number":["TR001082"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences Clinical and Translational Science","doi-asserted-by":"publisher","award":["RR025758"],"award-info":[{"award-number":["RR025758"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences Clinical and Translational Science","doi-asserted-by":"publisher","award":["TR001102"],"award-info":[{"award-number":["TR001102"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences Clinical and Translational Science","doi-asserted-by":"publisher","award":["RR033179"],"award-info":[{"award-number":["RR033179"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences Clinical and Translational Science","doi-asserted-by":"publisher","award":["TR000001"],"award-info":[{"award-number":["TR000001"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences Clinical and Translational Science","doi-asserted-by":"publisher","award":["RR024989"],"award-info":[{"award-number":["RR024989"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences Clinical and Translational Science","doi-asserted-by":"publisher","award":["TR000439"],"award-info":[{"award-number":["TR000439"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources General Clinical Research Centers","doi-asserted-by":"publisher","award":["RR000039"],"award-info":[{"award-number":["RR000039"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources General Clinical Research Centers","doi-asserted-by":"publisher","award":["RR000585"],"award-info":[{"award-number":["RR000585"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources General Clinical Research Centers","doi-asserted-by":"publisher","award":["RR000054"],"award-info":[{"award-number":["RR000054"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources General Clinical Research Centers","doi-asserted-by":"publisher","award":["RR000051"],"award-info":[{"award-number":["RR000051"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources General Clinical Research Centers","doi-asserted-by":"publisher","award":["RR023940"],"award-info":[{"award-number":["RR023940"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources General Clinical Research Centers","doi-asserted-by":"publisher","award":["RR001032"],"award-info":[{"award-number":["RR001032"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK62402"],"award-info":[{"award-number":["DK62402"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK62411"],"award-info":[{"award-number":["DK62411"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK62410"],"award-info":[{"award-number":["DK62410"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK082230"],"award-info":[{"award-number":["DK082230"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK62408"],"award-info":[{"award-number":["DK62408"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK62401"],"award-info":[{"award-number":["DK62401"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CHYR"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Epidemiological studies have suggested that elevated serum uric acid may\ncontribute to the progression of chronic kidney disease. However, no large prospective study has\nexamined whether hyperuricemia is an independent risk factor for the progression of autosomal\ndominant polycystic kidney disease (ADPKD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We measured uric acid in stored serum samples from the 2-year study visit of 671 participants\nfrom the HALT PKD multicenter trials. Participants were categorized according to uric acid\ntertiles. For Study A (participants aged 15-49 years with preserved kidney function, n=350), we\nused linear mixed effects models to examine the association between uric acid and repeated measures\nof height-adjusted total kidney volume (htTKV), the primary outcome for Study A. For\nStudy B (participants aged 18-64 with decreased kidney function, n=321), we used Cox proportional\nhazards models to assess the hazard for the combined endpoint of 50% loss in estimated glomerular\nfiltration rate (eGFR), end-stage kidney disease (ESKD), or death, the primary outcome for\nStudy B. To assess the association of uric acid with the slope of eGFR decline (secondary outcome\nof HALT A and B), we used linear mixed effects models for the combined population of Study A\nand B.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In the unadjusted model, the annual change in htTKV was 2.7% higher in the highest uric\nacid tertile compared to the lowest (p&lt;0.001), but this difference became insignificant after adjustment\nfor gender. Men had faster TKV growth than women (p&lt;0.001). There was no difference in\neGFR decline between the 3 uric acid tertiles. Hazard ratios for the clinical endpoint were 2.9 (95%\nconfidence interval, 1.9-4.4) and 1.8 (1.1-2.8) respectively in the high and medium uric acid groups\nin unadjusted and partially adjusted models (p&lt;0.001), but the significance was lost after adjustment\nfor baseline eGFR. Results were similar when uric acid was examined as a continuous variable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Elevated serum uric acid is not an independent risk factor for disease progression in ADPKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1573402116666200817113125","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T04:08:42Z","timestamp":1597723722000},"page":"228-237","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Serum Uric Acid and Progression of Autosomal Dominant Polycystic Kidney Disease: Results from the HALT PKD Trials"],"prefix":"10.2174","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2076-9856","authenticated-orcid":true,"given":"Godela M.","family":"Brosnahan","sequence":"first","affiliation":[{"name":"University of Colorado Anschutz Medical Campus, Aurora, Colorado,United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"You","sequence":"additional","affiliation":[{"name":"University of Colorado Anschutz Medical Campus, Aurora, Colorado,United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-3359","authenticated-orcid":true,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"University of Colorado Anschutz Medical Campus, Aurora, Colorado,United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7457-6497","authenticated-orcid":true,"given":"Berenice Y.","family":"Gitomer","sequence":"additional","affiliation":[{"name":"University of Colorado Anschutz Medical Campus, Aurora, Colorado,United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Chonchol","sequence":"additional","affiliation":[{"name":"University of Colorado Anschutz Medical Campus, Aurora, Colorado,United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"1356","volume":"32","author":"Willey C.J.","year":"2017","unstructured":"Willey C.J.; Blais J.D.; Hall A.K.; Krasa H.B.; Makin A.J.; Czerwiec F.S.; Prevalence of autosomal dominant polycystic kidney disease in the European Union. Nephrol Dial Transplant 2017,32(8),1356-1363","journal-title":"Nephrol Dial Transplant"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1681\/ASN.2018050493","volume":"29","author":"Lanktree M.B.","year":"2018","unstructured":"Lanktree M.B.; Haghighi A.; Guiard E.; Iliuta I.A.; Song X.; Harris P.C.; Paterson A.D.; Pei Y.; Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing. J Am Soc Nephrol 2018,29(10),2593-2600","journal-title":"J Am Soc Nephrol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2215\/CJN.05900519","volume":"15","author":"Suwabe T.","year":"2020","unstructured":"Suwabe T.; Shukoor S.; Chamberlain A.M.; Killian J.M.; King B.F.; Edwards M.; Senum S.R.; Madsen C.D.; Chebib F.T.; Hogan M.C.; Cornec-Le Gall E.; Harris P.C.; Torres V.E.; Epidemiology of autosomal dominant polycystic kidney disease in Olmsted County. Clin J Am Soc Nephrol 2020,15(1),69-79","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"Torres V.E.","year":"2012","unstructured":"Torres V.E.; Chapman A.B.; Devuyst O.; Gansevoort R.T.; Grantham J.J.; Higashihara E.; Perrone R.D.; Krasa H.B.; Ouyang J.; Czerwiec F.S.; Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med TEMPO 3:4 Trial Investigators2012,367(25),2407-2418","journal-title":"N Engl J Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/ki.1992.195","volume":"41","author":"Gabow P.A.","year":"1992","unstructured":"Gabow P.A.; Johnson A.M.; Kaehny W.D.; Kimberling W.J.; Lezotte D.C.; Duley I.T.; Jones R.H.; Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 1992,41(5),1311-1319","journal-title":"Kidney Int"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.V8101560","volume":"8","author":"Johnson A.M.","year":"1997","unstructured":"Johnson A.M.; Gabow P.A.; Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol 1997,8(10),1560-1567","journal-title":"J Am Soc Nephrol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.2215\/CJN.03250410","volume":"6","author":"Torres V.E.","year":"2011","unstructured":"Torres V.E.; Grantham J.J.; Chapman A.B.; Mrug M.; Bae K.T.; King B.F.; Wetzel L.H.; Martin D.; Lockhart M.E.; Bennett W.M.; Moxey-Mims M.; Abebe K.Z.; Lin Y.; Bost J.E.; Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP)2011,6(3),640-647","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1681\/ASN.2013111184","volume":"25","author":"Schrier R.W.","year":"2014","unstructured":"Schrier R.W.; Brosnahan G.; Cadnapaphornchai M.A.; Chonchol M.; Friend K.; Gitomer B.; Rossetti S.; Predictors of autosomal dominant polycystic kidney disease progression. J Am Soc Nephrol 2014,25(11),2399-2418","journal-title":"J Am Soc Nephrol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1097\/01.ASN.0000034910.58454.FD","volume":"13","author":"Kang D.H.","year":"2002","unstructured":"Kang D.H.; Nakagawa T.; Feng L.; Watanabe S.; Han L.; Mazzali M.; Truong L.; Harris R.; Johnson R.J.; A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002,13(12),2888-2897","journal-title":"J Am Soc Nephrol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1097\/HJH.0b013e328337da1d","volume":"28","author":"Yu M.A.","year":"2010","unstructured":"Yu M.A.; S\u00e1nchez-Lozada L.G.; Johnson R.J.; Kang D.H.; Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens 2010,28(6),1234-1242","journal-title":"J Hypertens"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","volume":"64","author":"Wang D.","year":"2003","unstructured":"Wang D.; Iversen J.; Wilcox C.S.; Strandgaard S.; Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease. Kidney Int 2003,64(4),1381-1388","journal-title":"Kidney Int"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2215\/CJN.05850518","volume":"13","author":"Nowak K.L.","year":"2018","unstructured":"Nowak K.L.; Wang W.; Farmer-Bailey H.; Gitomer B.; Malaczewski M.; Klawitter J.; Jovanovich A.; Chonchol M.; Vascular dysfunction, oxidative stress, and inflammation in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2018,13(10),1493-1501","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2215\/CJN.11451210","volume":"6","author":"Kanbay M.","year":"2011","unstructured":"Kanbay M.; Huddam B.; Azak A.; Solak Y.; Kadioglu G.K.; Kirbas I.; Duranay M.; Covic A.; Johnson R.J.; A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol 2011,6(8),1887-1894","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039738","volume":"7","author":"Zhou Y.","year":"2012","unstructured":"Zhou Y.; Fang L.; Jiang L.; Wen P.; Cao H.; He W.; Dai C.; Yang J.; Uric acid induces renal inflammation via activating tubular NF-\u03baB signaling pathway. PLoS One 2012,7(6)","journal-title":"PLoS One"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12882-017-0736-x","volume":"18","author":"Romi M.M.","year":"2017","unstructured":"Romi M.M.; Arfian N.; Tranggono U.; Setyaningsih W.A.W.; Sari D.C.R.; Uric acid causes kidney injury through inducing fibroblast expansion, Endothelin-1 expression, and inflammation. BMC Nephrol 2017,18(1),326","journal-title":"BMC Nephrol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.ajkd.2017.12.009","volume":"71","author":"Johnson R.J.","year":"2018","unstructured":"Johnson R.J.; Bakris G.L.; Borghi C.; Chonchol M.B.; Feldman D.; Lanaspa M.A.; Merriman T.R.; Moe O.W.; Mount D.B.; Sanchez Lozada L.G.; Stahl E.; Weiner D.E.; Chertow G.M.; Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney Foundation. Am J Kidney Dis 2018,71(6),851-865","journal-title":"Am J Kidney Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/nep.12045","volume":"18","author":"Ta M.H.","year":"2013","unstructured":"Ta M.H.; Harris D.C.; Rangan G.K.; Role of interstitial inflammation in the pathogenesis of polycystic kidney disease. Nephrology (Carlton) 2013,18(5),317-330","journal-title":"Nephrology (Carlton)"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nrneph.2011.109","volume":"7","author":"Grantham J.J.","year":"2011","unstructured":"Grantham J.J.; Mulamalla S.; Swenson-Fields K.I.; Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 2011,7(10),556-566","journal-title":"Nat Rev Nephrol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2215\/CJN.04310709","volume":"5","author":"Chapman A.B.","year":"2010","unstructured":"Chapman A.B.; Torres V.E.; Perrone R.D.; Steinman T.I.; Bae K.T.; Miller J.P.; Miskulin D.C.; Rahbari Oskoui F.; Masoumi A.; Hogan M.C.; Winklhofer F.T.; Braun W.; Thompson P.A.; Meyers C.M.; Kelleher C.; Schrier R.W.; The HALT polycystic kidney disease trials: design and implementation. Clin J Am Soc Nephrol 2010,5(1),102-109","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","volume":"371","author":"Schrier R.W.","year":"2014","unstructured":"Schrier R.W.; Abebe K.Z.; Perrone R.D.; Torres V.E.; Braun W.E.; Steinman T.I.; Winklhofer F.T.; Brosnahan G.; Czarnecki P.G.; Hogan M.C.; Miskulin D.C.; Rahbari-Oskoui F.F.; Grantham J.J.; Harris P.C.; Flessner M.F.; Bae K.T.; Moore C.G.; Chapman A.B.; Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med HALT-PKD Trial Investigators2014,371(24),2255-2266","journal-title":"N Engl J Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","volume":"371","author":"Torres V.E.","year":"2014","unstructured":"Torres V.E.; Abebe K.Z.; Chapman A.B.; Schrier R.W.; Braun W.E.; Steinman T.I.; Winklhofer F.T.; Brosnahan G.; Czarnecki P.G.; Hogan M.C.; Miskulin D.C.; Rahbari-Oskoui F.F.; Grantham J.J.; Harris P.C.; Flessner M.F.; Moore C.G.; Perrone R.D.; Angiotensin blockade in late autosomal dominant polycystic kidney disease. N Engl J Med HALT-PKD Trial Investigators2014,371(24),2267-2276","journal-title":"N Engl J Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","volume":"64","author":"Chapman A.B.","year":"2003","unstructured":"Chapman A.B.; Guay-Woodford L.M.; Grantham J.J.; Torres V.E.; Bae K.T.; Baumgarten D.A.; Kenney P.J.; King B.F.; Glockner J.F.; Wetzel L.H.; Brummer M.E.; O\u2019Neill W.C.; Robbin M.L.; Bennett W.M.; Klahr S.; Hirschman G.H.; Kimmel P.L.; Thompson P.A.; Miller J.P.; Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort2003,64(3),1035-1045","journal-title":"Kidney Int"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"Levey A.S.","year":"2009","unstructured":"Levey A.S.; Stevens L.A.; Schmid C.H.; Zhang Y.L.; Castro A.F.; Feldman H.I.; Kusek J.W.; Eggers P.; Van Lente F.; Greene T.; Coresh J.; A new equation to estimate glomerular filtration rate. Ann Intern Med CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)[Erratum in: Ann Intern Med 2011; 155: 4082009,150(9),604-612","journal-title":"Ann Intern Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1681\/ASN.2015050583","volume":"27","author":"Heyer C.M.","year":"2016","unstructured":"Heyer C.M.; Sundsbak J.L.; Abebe K.Z.; Chapman A.B.; Torres V.E.; Grantham J.J.; Bae K.T.; Schrier R.W.; Perrone R.D.; Braun W.E.; Steinman T.I.; Mrug M.; Yu A.S.; Brosnahan G.; Hopp K.; Irazabal M.V.; Bennett W.M.; Flessner M.F.; Moore C.G.; Landsittel D.; Harris P.C.; Predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease. J Am Soc Nephrol HALT PKD and CRISP Investigators2016,27(9),2872-2884","journal-title":"J Am Soc Nephrol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1681\/ASN.2007101075","volume":"19","author":"Weiner D.E.","year":"2008","unstructured":"Weiner D.E.; Tighiouart H.; Elsayed E.F.; Griffith J.L.; Salem D.N.; Levey A.S.; Uric acid and incident kidney disease in the community. J Am Soc Nephrol 2008,19(6),1204-1211","journal-title":"J Am Soc Nephrol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1053\/j.ajkd.2010.01.019","volume":"56","author":"Bellomo G.","year":"2010","unstructured":"Bellomo G.; Venanzi S.; Verdura C.; Saronio P.; Esposito A.; Timio M.; Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis 2010,56(2),264-272","journal-title":"Am J Kidney Dis"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.2337\/db09-0014","volume":"58","author":"Hovind P.","year":"2009","unstructured":"Hovind P.; Rossing P.; Tarnow L.; Johnson R.J.; Parving H.H.; Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study. Diabetes 2009,58(7),1668-1671","journal-title":"Diabetes"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2215\/CJN.03140315","volume":"10","author":"De Cosmo S.","year":"2015","unstructured":"De Cosmo S.; Viazzi F.; Pacilli A.; Giorda C.; Ceriello A.; Gentile S.; Russo G.; Rossi M.C.; Nicolucci A.; Guida P.; Feig D.; Johnson R.J.; Pontremoli R.; Serum uric acid and risk of CKD in type 2 diabetes. Clin J Am Soc Nephrol AMD-Annals Study Group2015,10(11),1921-1929","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/ndt\/gfm783","volume":"23","author":"S\u00e1nchez-Lozada L.G.","year":"2008","unstructured":"S\u00e1nchez-Lozada L.G.; Tapia E.; Soto V.; Avila-Casado C.; Franco M.; Zhao L.; Johnson R.J.; Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia. Nephrol Dial Transplant 2008,23(4),1179-1185","journal-title":"Nephrol Dial Transplant"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10157-012-0609-3","volume":"16","author":"Omori H.","year":"2012","unstructured":"Omori H.; Kawada N.; Inoue K.; Ueda Y.; Yamamoto R.; Matsui I.; Kaimori J.; Takabatake Y.; Moriyama T.; Isaka Y.; Rakugi H.; Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy. Clin Exp Nephrol 2012,16(4),549-556","journal-title":"Clin Exp Nephrol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12882-019-1275-4","volume":"20","author":"Fan S.","year":"2019","unstructured":"Fan S.; Zhang P.; Wang A.Y.; Wang X.; Wang L.; Li G.; Hong D.; Hyperuricemia and its related histopathological features on renal biopsy. BMC Nephrol 2019,20(1),95","journal-title":"BMC Nephrol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2337\/dc18-2173","volume":"42","author":"Pilemann-Lyberg S.","year":"2019","unstructured":"Pilemann-Lyberg S.; Hansen T.W.; Tofte N.; Winther S.A.; Theilade S.; Ahluwalia T.S.; Rossing P.; Uric acid is an independent risk factor for decline in kidney function, cardiovascular events, and mortality in patients with type 1 diabetes. Diabetes Care 2019,42(6),1088-1094","journal-title":"Diabetes Care"},{"key":"ref=33","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy138","author":"Hanai K.","year":"2018","unstructured":"Hanai K.; Tauchi E.; Nishiwaki Y.; Effects of uric acid on kidney function decline differ depending on baseline kidney function in type 2 diabetic patients. Nephrol Dial Transplant Epub ahead of print2018","journal-title":"Nephrol Dial Transplant"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000464260","volume":"45","author":"Kuwabara M.","year":"2017","unstructured":"Kuwabara M.; Bjornstad P.; Hisatome I.; Niwa K.; Roncal-Jimenez C.A.; Andres-Hernando A.; Jensen T.; Milagres T.; Sato Y.; Garcia G.; Ohno M.; Lanaspa M.A.; Johnson R.J.; Elevated serum uric acid level predicts rapid decline in kidney function. Am J Nephrol 2017,45(4),330-337","journal-title":"Am J Nephrol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/ndt\/gfx297","volume":"33","author":"Tsai C.W.","year":"2018","unstructured":"Tsai C.W.; Chiu H.T.; Huang H.C.; Ting I.W.; Yeh H.C.; Kuo C.C.; Uric acid predicts adverse outcomes in chronic kidney disease: a novel insight from trajectory analyses. Nephrol Dial Transplant 2018,33(2),231-241","journal-title":"Nephrol Dial Transplant"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1053\/j.ajkd.2017.08.017","volume":"71","author":"Srivastava A.","year":"2018","unstructured":"Srivastava A.; Kaze A.D.; McMullan C.J.; Isakova T.; Waikar S.S.; Uric acid and the risks of kidney failure and death in individuals with CKD. Am J Kidney Dis 2018,71(3),362-370","journal-title":"Am J Kidney Dis"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/ndt\/gfs417","volume":"28","author":"Helal I.","year":"2013","unstructured":"Helal I.; McFann K.; Reed B.; Yan X-D.; Schrier R.W.; Fick-Brosnahan G.M.; Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease. Nephrol Dial Transplant 2013,28(2),380-385","journal-title":"Nephrol Dial Transplant"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000353730","volume":"123","author":"Kocyigit I.","year":"2013","unstructured":"Kocyigit I.; Yilmaz M.I.; Orscelik O.; Sipahioglu M.H.; Unal A.; Eroglu E.; Kalay N.; Tokgoz B.; Axelsson J.; Oymak O.; Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease. Nephron Clin Pract 2013,123(3-4),157-164","journal-title":"Nephron Clin Pract"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/ndt\/gfu044","volume":"30","author":"Mao Z.","year":"2015","unstructured":"Mao Z.; Xie G.; Ong A.C.; Metabolic abnormalities in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2015,30(2),197-203","journal-title":"Nephrol Dial Transplant"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1073\/pnas.0901249106","volume":"106","author":"Woodward O.M.","year":"2009","unstructured":"Woodward O.M.; K\u00f6ttgen A.; Coresh J.; Boerwinkle E.; Guggino W.B.; K\u00f6ttgen M.; Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA 2009,106(25),10338-10342","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/cen.12673","volume":"83","author":"Liu P.","year":"2015","unstructured":"Liu P.; Chen Y.; Wang B.; Zhang F.; Wang D.; Wang Y.; Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia: 3-year randomized parallel-controlled study. Clin Endocrinol (Oxf) 2015,83(4),475-482","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2215\/CJN.01580210","volume":"5","author":"Goicoechea M.","year":"2010","unstructured":"Goicoechea M.; de Vinuesa S.G.; Verdalles U.; Ruiz-Caro C.; Ampuero J.; Rinc\u00f3n A.; Arroyo D.; Lu\u00f1o J.; Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 2010,5(8),1388-1393","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1053\/j.ajkd.2018.06.028","volume":"72","author":"Kimura K.","year":"2018","unstructured":"Kimura K.; Hosoya T.; Uchida S.; Inaba M.; Makino H.; Maruyama S.; Ito S.; Yamamoto T.; Tomino Y.; Ohno I.; Shibagaki Y.; Iimuro S.; Imai N.; Kuwabara M.; Hayakawa H.; Ohtsu H.; Ohashi Y.; Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial. Am J Kidney Dis FEATHER Study Investigators2018,72(6),798-810","journal-title":"Am J Kidney Dis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","volume":"382","year":"2020","unstructured":"N Engl J Med Badve SV, Pascoe EM, Tiku A, et al. Effects of allopurinol on the progression of chronic kidney disease2020,382(8),2504-13","journal-title":"N Engl J Med"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1056\/NEJMoa1916624","volume":"382","year":"2020","unstructured":"Doria A, Galecki AT, Spino C, et al. Serum urate lowering with allopurinol and kidney function in type 1 diabetes. N Engl J Med 2020,382(8),2493-2503","journal-title":"N Engl J Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"j2376","DOI":"10.1136\/bmj.j2376","volume":"357","year":"2017","unstructured":"Li X, Meng X, Timofeeva M, et al. Serum uric acid levels and\nmultiple health outcomes: umbrella review of evidence from observational\nstudies, randomised controlled trials, and Mendelian randomisation\nstudies. BMJ 2017,357,j2376","journal-title":"BMJ"},{"key":"ref=47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002725","volume":"16","author":"Jordan D.M.","year":"2019","unstructured":"Jordan D.M.; Choi H.K.; Verbanck M.; Topless R.; Won H.H.; Nadkarni G.; Merriman T.R.; Do R.; No causal effects of serum urate levels on the risk of chronic kidney disease: A Mendelian randomization study. PLoS Med 2019,16(1)","journal-title":"PLoS Med"}],"container-title":["Current Hypertension Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573402116666200817113125","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184892\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573402116666200817113125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T01:11:40Z","timestamp":1660007500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184892\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573402116666200817113125","relation":{},"ISSN":["1573-4021"],"issn-type":[{"value":"1573-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}